Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Pengwei Lv"'
Autor:
Qiyun Shi, Xiaowei Qi, Peng Tang, Linjun Fan, Li Chen, Shushu Wang, Yan Liang, Ying Hu, Minghao Wang, Lin Ren, Guozhi Zhang, Xuanni Tan, Long Yuan, Junze Du, Xiujuan Wu, Mengyuan Wang, Hongying Che, Pengwei Lv, Dejie Chen, Jinhui Hu, Qiuyun Li, Yanwu Zhang, Kunxian Yang, Yuan Zhong, Chuang Chen, Zemin Zhou, Liyuan Qian, Jingwei Zhang, Mingde Ma, Yi Sun, Yi Zhang, Jun Jiang
Publikováno v:
MedComm, Vol 4, Iss 6, Pp n/a-n/a (2023)
Abstract The objective of this multicenter, single‐arm trial (ChiCTR1900022293) was to explore the efficacy and safety of neoadjuvant therapy with epirubicin, cyclophosphamide, and pyrotinib followed by docetaxel, trastuzumab, and pyrotinib (ECPy
Externí odkaz:
https://doaj.org/article/e40c5317040147cfa459d5a75cf65c6d
Publikováno v:
Biomedical Journal, Vol 45, Iss 3, Pp 512-521 (2022)
Background: Long non-coding RNA (lncRNA) is an endogenous RNA over 200 nt in length involved in gene regulation. LINC01559 is a novel lncRNA that has been identified as a fundamental player in human cancer. However, its role in triple-negative breast
Externí odkaz:
https://doaj.org/article/2a327304fe3544a0bd11ed2a82c3afa4
Publikováno v:
Cell Death and Disease, Vol 12, Iss 4, Pp 1-14 (2021)
Abstract Aberrant expression of miR-30d is associated with the development and progression of several human cancers. However, its biological roles and underlying mechanisms in pancreatic cancer are largely unknown. The expression of miR-30d in pancre
Externí odkaz:
https://doaj.org/article/667ef0a3a43e4e4d9700f6008a02b0f5
Autor:
Xiaoyun Mao, Pengwei Lv, Yiping Gong, Xiujuan Wu, Peng Tang, Shushu Wang, Dianlong Zhang, Wei You, Ouchen Wang, Jun Zhou, Jingruo Li, Feng Jin
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundPyrotinib, a small-molecule tyrosine kinase inhibitor, has been investigated as a component of neoadjuvant therapy in phase 2 trials of human epidermal growth factor receptor 2 (HER2)-positive breast cancer. This study aimed to evaluate the
Externí odkaz:
https://doaj.org/article/f7ef6d0e744946b5bcd02cf4338054f9
Autor:
Fang Wang, Xiaochun Wang, Jingruo Li, Pengwei Lv, Mingli Han, Lin Li, Zhuo Chen, Lingling Dong, Nan Wang, Yuanting Gu
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-16 (2021)
Abstract Background Circular RNAs (circRNAs) have caught increasing attentions and interests for their important involvement in cancer initiation and progression. This study aims to investigate the biological functions of circNOL10 and its potential
Externí odkaz:
https://doaj.org/article/51a7ca969c644f398ae6eac6b598d74c
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background The survival of pancreatic cancer patients remains poor. However, the underlying molecular mechanism and new therapeutic target of pancreatic cancer are still needed to be found. Many studies have shown that the IGF2 mRNA-binding
Externí odkaz:
https://doaj.org/article/acbf0bbe4e9f447fb633e80f803f1a67
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 110, Iss , Pp 294-301 (2019)
The long non-coding RNA (lncRNA) has recently been shown to be important regulators involved in the progression of various human cancers. Small nucleolar RNA host gene 6 (SNHG6) is a recently identified cancer-related lncRNA. However, the clinical si
Externí odkaz:
https://doaj.org/article/83b6da26776347909c5e5f6f5c2ae264
Autor:
Yin Mi, Pengwei Lv, Fang Wang, Lin Li, Mingzhi Zhu, Yanyan Wang, Yingying Zhang, Lele Liu, Qinchen Cao, Meilian Dong, Yonggang Shi, Ruitai Fan, Jingruo Li, Yuanting Gu, Xiaoxiao Zuo
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: To investigate the efficacy of targeted intraoperative radiotherapy (TARGIT) vs. conventional external beam radiotherapy (EBRT) in Chinese patients with breast cancer.Methods: We retrospectively analyzed breast cancer patients who underwent
Externí odkaz:
https://doaj.org/article/e59fced4a68946ddbe1b4533ee36a55b
Autor:
Fang Wang, Xiaochun Wang, Jingruo Li, Pengwei Lv, Mingli Han, Lin Li, Zhuo Chen, Lingling Dong, Nan Wang, Yuanting Gu
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/d0b377efd7e0416698f14e771c77e1b9
Autor:
Qiyun Shi, Xiaowei Qi, Peng Tang, Linjun Fan, Li Chen, Shushu Wang, Guozhi Zhang, Mengyuan Wang, Hongying Che, Pengwei Lv, Dejie Chen, Jinhui Hu, Qiuyun Li, Yanwu Zhang, Qiao Yu, Kunxian Yang, Yuan Zhong, Chuang Chen, Zemin Zhou, Liyuan Qian, Jingwei Zhang, Mingde Ma, Yi Sun, Jiangbo Liu, Yi Zhang, Jun Jiang
Publikováno v:
Cancer Research. 83:OT2-22
Background: Dual HER2 targeted therapy with pyrotinib (a tyrosine kinase inhibitor targeting HER1, HER2, and HER4) and trastuzumab plus chemotherapy has been approved as neoadjuvant therapy for patients with HER2-positive breast cancer in China based